Navigation Links
China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
Date:10/2/2008

- Transaction to create the largest non-state-owned producers of

plasma-based product in China

TAIAN CITY, China, Oct. 2 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 26, 2008, the Company has agreed to acquire a 90% controlling interest in Chongqing Dalin Biologic Technologies Co., Ltd. ("Dalin"). Dalin owns 54% of the equity interest in Qianfeng Biological Products Co., Ltd. ("Qianfeng"), one of the largest plasma-based biopharmaceutical companies in China, located in Guiyang, Guizhou Province. The transaction is expected to be completed within two months.
Expected benefits of the acquisition include:

-- Increased plasma collection to almost double current levels and

significant increase in production capacity

-- Significant increase in commercial scale and expansion into Guizhou

Province

-- Opportunity for synergies through leveraging China Biologic's existing

sales and administrative infrastructure, as well as consolidating

research and development efforts

-- Opportunity to increase prices for Qianfeng's product line through

China Biologic's strong brand name and higher value product positioning

-- Use of Qianfeng's technological know-how to achieve higher yields per

unit of plasma input and raise overall efficiencies

"This acquisition will transform our Company to become the largest non-state-owned producer of plasma-based biopharmaceutical products in China, in terms of market share and production capacity," said Mr. Chao Ming Zhao, CEO of China Biologic Products. "We expect that this transaction will allow us to increase our supply of plasma by almost doubling our collection quantity, expand our product por
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 LayerBio is an MIT ... wound care. The National Eye Institute (NEI) at the ... Phase I SBIR grant to develop a drug-eluting intraocular ... most common cause of vision loss in people over ... According to Dr. Ken Mandell, LayerBio’s Founder and CEO, ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 In contrast ... of LEDs with various colors, Valoya uses proprietary LED ... This offers best possible uniformity which is critical in ... and high spectral accuracy throughout its lifetime which is ... LED tubes. , "The investment cost was clearly ...
(Date:12/19/2014)... 2014 Egenix, Inc. is pleased to announce that ... the Board, to succeed Donald Fresne ; Mr. Fresne ... as a member of the Board.  In recognition of the ... company over almost twenty years, the Board designated Mr. Fresne ... has established a Search Committee to find a suitable replacement ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Based ... the overall surgical imaging market is dominated by ... the surgical imaging market. These players include GE ... Ziehm Imaging (Germany). , Full Report Copy ... of GE Healthcare can be attributed to its ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) ... Patent, # 7,731,951 entitled "Viruses for the Treatment of Cellular Proliferative ... by administering modified vaccinia virus to proliferating cells having an activated ... "This ...
... , ASHBURN, Va. , June 17 Innocoll Inc. today ... to the post of chairman of the board, effective immediately.  Dr. Wild succeeds ... chairman since the company,s inception. , ... Dr. Wild has served as a director of the company since July ...
... , REDWOOD CITY, Calif. , June 17 ... today announced a global strategic alliance to discover, develop and commercialize ... stem cells are a subset of tumor cells believed to play ...   , , , ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent 2Innocoll Announces Appointment of Anthony H. Wild Ph.D. to Chairman of the Board 2Innocoll Announces Appointment of Anthony H. Wild Ph.D. to Chairman of the Board 3OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 2OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 3OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 4OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 5
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... send water surging through swamps and marshes near rivers and ... emissions from those affected wetlands, according to recent research at ... water through wetlands result in lower average emissions of greenhouse ... emissions from wetlands that receive a steady flow of water. ...
... Medical Center scientists have made a significant finding that ... including Huntington,s disease and Alzheimer,s disease. Compounds that block ... and greatly improved survival in fruit flies that had ... "We were able to prevent Huntington,s disease-like illness in ...
... research team, led by investigators at the Department of Surgery ... Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" ... a deadly diphtheria toxin gene. The findings set ... Biology & Therapy reflect the first time this ...
Cached Biology News:Flooding might help lower gas emission from wetlands 2Flooding might help lower gas emission from wetlands 3Duke team finds compounds that prevent nerve damage 2Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 2Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 3
Human DCIR/CLEC4A Phycoerythrin MAb (Clone 216110)...
Contains 100 positive controls for effective screening of HDAC inhibitors by fluorometric method....
One-step, microplate or cuvet, colorimetric 530nm, detection limit 0.16mg/dL in serum or plasma. Procedure: 10 min....
RABBIT ANTI HUMAN CHYMOTRYPSIN...
Biology Products: